Articles

Antidepressants based on ketamine?

Finding out the molecular mechanism by which ketamine quickly and effectively eliminates the symptoms of depression opens the way for the creation of antidepressants similar to ketamine in action, but more convenient and safe.

Oncogenes and anti-oncogenes: who's who?

The development of malignant tumors in the body is opposed by the anti-cancer protection system. Its main participant, the anti-oncogene p53, has been known for a long time, but until now scientists did not understand what makes it activate.

Presidential Awards in the field of science and innovation for young scientists

This prize is awarded to young scientists and specialists of the Russian Federation for their significant contribution to the development of Russian science and innovation.

Embryonic stem cells were again blocked from oxygen

The Alliance Defense Fund, a public organization dedicated to protecting the interests of adherents of various Christian denominations, filed a lawsuit to cancel state funding for embryonic stem cell research.

Pure BRCA2

Three research groups managed to isolate the BRCA2 protein in its pure form, corresponding to a gene in which mutations are associated with the development of breast and ovarian cancer.

Resveratrol and sirtuins: to be continued

The discussion continues about the ability of resveratrol and its analogues to activate the work of sirtuins "in vitro" and in a living organism.

PhD programs within the framework of the Marie Curie Campaign

As part of the Marie Curie Campaign, talented masters working on a dissertation in the field of biological, chemical, medical or other related sciences can take an internship at the Max F. Perutz laboratories of the Vienna Biological Center.

Only old people live here

The village of Fairhall is Britain's first residential complex for the elderly. Now the Scottish government is considering a plan to build a whole network of such villages where elderly people could live a full life in nature in peace and comfort.

Genentech's Success Story

Since its birth, Genentech has not conceded leadership in biotechnology. For twelve years in a row, including in 2010, Fortune has named Genentech one of the best companies worth working for, and last year Science named it the best employer in biotech.

IV International Congress of Molecular Medicine

The Fourth International Congress of Molecular Medicine will be held in Istanbul on June 27-30, 2011.

Demographic crisis in Russia: a look from across the ocean

The authoritative American demographer and political economist Nicholas Eberstadt presented the report "The Russian demographic crisis of peacetime: dimensions, causes, consequences" at the Washington Hudson Institute.

"Mitochondrial Eve" has aged one and a half times?

According to new data, taking into account the latest achievements in the field of population genetics, "mitochondrial Eve" lived about 200 thousand years ago. Previously, the age of the hypothetical mother of mankind was estimated at 140 thousand years.

Innovative way of development: the voice of the people

13% of respondents called the talk about a new way of development empty words. In Russia, an innovative way of development is impossible – 4% are convinced of this. The same number believe that the new way is the "scam of the century". 23% found it difficult to answer.

Russian-Israeli Competition of Nanotechnology Projects

Joint research projects for the application of nanotechnology in medicine and healthcare, biotechnology, agriculture and other fields can be submitted to the competition.

Pill for old age part6

Pill for old age part4

Pill for old age part3

Pill for old age part2

Pill for old age part1

How the safety of the HIV vaccine was tested on me

An entry from the diary of one of the voluntary participants of the 1st phase of clinical trials of the domestic HIV vaccine – Combivichvak.